DK3371310T3 - Nucleinsyrekonstruerede targetnucleinsyrer - Google Patents
Nucleinsyrekonstruerede targetnucleinsyrer Download PDFInfo
- Publication number
- DK3371310T3 DK3371310T3 DK16822804.7T DK16822804T DK3371310T3 DK 3371310 T3 DK3371310 T3 DK 3371310T3 DK 16822804 T DK16822804 T DK 16822804T DK 3371310 T3 DK3371310 T3 DK 3371310T3
- Authority
- DK
- Denmark
- Prior art keywords
- nucleic acid
- constructed target
- nucleic acids
- acid constructed
- target nucleic
- Prior art date
Links
- 150000007523 nucleic acids Chemical class 0.000 title 2
- 102000039446 nucleic acids Human genes 0.000 title 2
- 108020004707 nucleic acids Proteins 0.000 title 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/51—Physical structure in polymeric form, e.g. multimers, concatemers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/52—Physical structure branched
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Mycology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562263232P | 2015-12-04 | 2015-12-04 | |
| PCT/US2016/064860 WO2017096328A1 (en) | 2015-12-04 | 2016-12-02 | Engineered nucleic-acid targeting nucleic acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3371310T3 true DK3371310T3 (da) | 2019-08-05 |
Family
ID=57750577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16822804.7T DK3371310T3 (da) | 2015-12-04 | 2016-12-02 | Nucleinsyrekonstruerede targetnucleinsyrer |
Country Status (17)
| Country | Link |
|---|---|
| US (4) | US9771600B2 (da) |
| EP (2) | EP3564371B1 (da) |
| JP (1) | JP6707133B2 (da) |
| KR (1) | KR102093570B1 (da) |
| CN (1) | CN108473981B (da) |
| AU (2) | AU2016363024B2 (da) |
| CA (1) | CA3004757C (da) |
| DK (1) | DK3371310T3 (da) |
| ES (1) | ES2735773T3 (da) |
| HK (1) | HK1252755B (da) |
| IL (1) | IL259148B (da) |
| MX (1) | MX391311B (da) |
| NZ (2) | NZ756843A (da) |
| RU (1) | RU2018117360A (da) |
| SG (1) | SG11201803593QA (da) |
| WO (1) | WO2017096328A1 (da) |
| ZA (1) | ZA201802968B (da) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108473981B (zh) * | 2015-12-04 | 2022-04-12 | 卡里布生物科学公司 | 工程化靶向核酸的核酸 |
| CA3209273A1 (en) * | 2016-06-02 | 2017-12-07 | Sigma-Aldrich Co. Llc | Using programmable dna binding proteins to enhance targeted genome modification |
| EP3555297A1 (en) | 2016-12-19 | 2019-10-23 | Editas Medicine, Inc. | Assessing nuclease cleavage |
| US11499151B2 (en) | 2017-04-28 | 2022-11-15 | Editas Medicine, Inc. | Methods and systems for analyzing guide RNA molecules |
| CN112501254B (zh) | 2017-07-14 | 2024-07-19 | 上海吐露港生物科技有限公司 | 一种Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒 |
| US11866726B2 (en) | 2017-07-14 | 2024-01-09 | Editas Medicine, Inc. | Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites |
| US11584955B2 (en) * | 2017-07-14 | 2023-02-21 | Shanghai Tolo Biotechnology Company Limited | Application of Cas protein, method for detecting target nucleic acid molecule and kit |
| WO2019041296A1 (zh) | 2017-09-01 | 2019-03-07 | 上海科技大学 | 一种碱基编辑系统及方法 |
| WO2019051428A1 (en) * | 2017-09-11 | 2019-03-14 | The Regents Of The University Of California | CAS9 ANTIBODY MEDIA ADMINISTRATION TO MAMMALIAN CELLS |
| WO2019152941A1 (en) | 2018-02-05 | 2019-08-08 | Caribou Biosciences, Inc. | Engineered gut microbes for reduction of reactivation of detoxified drugs |
| CN111699254A (zh) | 2018-02-08 | 2020-09-22 | 齐默尔根公司 | 使用crispr在棒状杆菌属中进行基因组编辑 |
| KR20210045360A (ko) | 2018-05-16 | 2021-04-26 | 신테고 코포레이션 | 가이드 rna 설계 및 사용을 위한 방법 및 시스템 |
| EP3823633A4 (en) | 2018-06-29 | 2023-05-03 | Editas Medicine, Inc. | SYNTHETIC LEAD MOLECULES, COMPOSITIONS AND METHODS RELATED THERETO |
| EA202190454A1 (ru) * | 2018-08-09 | 2021-04-22 | Джи+ФЛАС ЛАЙФ САЙЕНСИЗ | Новый crispr-ассоциированный белок и его применение |
| CN109517722B (zh) * | 2018-09-28 | 2022-04-01 | 德拜至臻医学科技(杭州)有限公司 | 一种捕获特定微量细胞的装置及其制作和使用方法 |
| CN113166202B (zh) | 2018-10-12 | 2024-09-13 | 治疗调适公司 | 包括β-磷酸三钙-结合序列的多肽及其用途 |
| WO2020176389A1 (en) | 2019-02-25 | 2020-09-03 | Caribou Biosciences, Inc. | Plasmids for gene editing |
| AU2020369599A1 (en) | 2019-10-23 | 2022-05-12 | Monsanto Technology Llc | Compositions and methods for RNA-templated editing in plants |
| CA3160186A1 (en) * | 2019-11-05 | 2021-05-14 | Pairwise Plants Services, Inc. | Compositions and methods for rna-encoded dna-replacement of alleles |
| US20230203115A1 (en) * | 2020-03-06 | 2023-06-29 | Theradaptive, Inc. | Therapeutic compositions comprising graft materials and beta-tcp binding peptides and uses thereof |
| US11453907B2 (en) * | 2020-03-23 | 2022-09-27 | The Broad Institute, Inc. | Crispr effector system based coronavirus diagnostics |
| JP2023525960A (ja) | 2020-04-15 | 2023-06-20 | セラダプティブ インク | 骨に標的治療薬を送達するための組成物および方法 |
| EP4347818A2 (en) | 2021-06-01 | 2024-04-10 | Arbor Biotechnologies, Inc. | Gene editing systems comprising a crispr nuclease and uses thereof |
| CN114540325B (zh) * | 2022-01-17 | 2022-12-09 | 广州医科大学 | 靶向dna去甲基化的方法、融合蛋白及其应用 |
| CN116377104B (zh) * | 2022-11-14 | 2024-01-12 | 海南省农业科学院蔬菜研究所 | 一种快菜高温胁迫内参基因及其引物及应用 |
| KR20250151430A (ko) | 2023-02-15 | 2025-10-21 | 아버 바이오테크놀로지스, 인크. | 스타스민 2(stmn2) 전사체에서 비정상적인 스플라이싱을 억제하는 유전자 편집 방법 |
| WO2025171210A1 (en) | 2024-02-09 | 2025-08-14 | Arbor Biotechnologies, Inc. | Compositions and methods for gene editing via homology-mediated end joining |
| WO2026015829A2 (en) | 2024-07-12 | 2026-01-15 | Arbor Biotechnologies, Inc. | Small reverse transcriptases and gene editing systems comprising such |
| WO2026015832A2 (en) | 2024-07-12 | 2026-01-15 | Arbor Biotechnologies, Inc. | Reverse transcriptases and gene editing systems comprising such |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10087431B2 (en) | 2010-03-10 | 2018-10-02 | The Regents Of The University Of California | Methods of generating nucleic acid fragments |
| MX2012013037A (es) | 2010-05-10 | 2013-07-29 | Univ California | Composiciones de endorribonucleasa y metodos de uso de las mismas. |
| JP2014529463A (ja) * | 2011-09-01 | 2014-11-13 | ヒップ・イノベーション・テクノロジー・エルエルシー | ライナを付けられた大腿骨カップ |
| US9637739B2 (en) * | 2012-03-20 | 2017-05-02 | Vilnius University | RNA-directed DNA cleavage by the Cas9-crRNA complex |
| AU2013266968B2 (en) | 2012-05-25 | 2017-06-29 | Emmanuelle CHARPENTIER | Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription |
| WO2013188638A2 (en) | 2012-06-15 | 2013-12-19 | The Regents Of The University Of California | Endoribonucleases and methods of use thereof |
| WO2014022702A2 (en) | 2012-08-03 | 2014-02-06 | The Regents Of The University Of California | Methods and compositions for controlling gene expression by rna processing |
| AU2013335451C1 (en) | 2012-10-23 | 2024-07-04 | Toolgen Incorporated | Composition for cleaving a target DNA comprising a guide RNA specific for the target DNA and Cas protein-encoding nucleic acid or Cas protein, and use thereof |
| WO2014093655A2 (en) | 2012-12-12 | 2014-06-19 | The Broad Institute, Inc. | Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains |
| EP2840140B2 (en) | 2012-12-12 | 2023-02-22 | The Broad Institute, Inc. | Crispr-Cas based method for mutation of prokaryotic cells |
| US20140310830A1 (en) | 2012-12-12 | 2014-10-16 | Feng Zhang | CRISPR-Cas Nickase Systems, Methods And Compositions For Sequence Manipulation in Eukaryotes |
| CN113355357B (zh) | 2012-12-12 | 2024-12-03 | 布罗德研究所有限公司 | 对用于序列操纵的改进的系统、方法和酶组合物进行的工程化和优化 |
| US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| IL239344B2 (en) * | 2012-12-12 | 2024-06-01 | Broad Inst Inc | Systems engineering, methods and optimal guiding components for sequence manipulation |
| RU2662932C2 (ru) | 2013-03-14 | 2018-07-31 | Карибо Биосайенсиз, Инк. | Композиции и способы с участием нуклеиновых кислот, нацеленных на нуклеиновые кислоты |
| CA2930877A1 (en) | 2013-11-18 | 2015-05-21 | Crispr Therapeutics Ag | Crispr-cas system materials and methods |
| WO2015089364A1 (en) * | 2013-12-12 | 2015-06-18 | The Broad Institute Inc. | Crystal structure of a crispr-cas system, and uses thereof |
| US20150376586A1 (en) | 2014-06-25 | 2015-12-31 | Caribou Biosciences, Inc. | RNA Modification to Engineer Cas9 Activity |
| US9650617B2 (en) * | 2015-01-28 | 2017-05-16 | Pioneer Hi-Bred International. Inc. | CRISPR hybrid DNA/RNA polynucleotides and methods of use |
| US9580727B1 (en) * | 2015-08-07 | 2017-02-28 | Caribou Biosciences, Inc. | Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides |
| CN108473981B (zh) * | 2015-12-04 | 2022-04-12 | 卡里布生物科学公司 | 工程化靶向核酸的核酸 |
-
2016
- 2016-12-02 CN CN201680071016.9A patent/CN108473981B/zh active Active
- 2016-12-02 KR KR1020187019090A patent/KR102093570B1/ko active Active
- 2016-12-02 EP EP19171356.9A patent/EP3564371B1/en active Active
- 2016-12-02 ES ES16822804T patent/ES2735773T3/es active Active
- 2016-12-02 EP EP16822804.7A patent/EP3371310B1/en active Active
- 2016-12-02 AU AU2016363024A patent/AU2016363024B2/en active Active
- 2016-12-02 US US15/368,570 patent/US9771600B2/en active Active
- 2016-12-02 SG SG11201803593QA patent/SG11201803593QA/en unknown
- 2016-12-02 NZ NZ756843A patent/NZ756843A/en unknown
- 2016-12-02 NZ NZ742040A patent/NZ742040A/en unknown
- 2016-12-02 JP JP2018528798A patent/JP6707133B2/ja active Active
- 2016-12-02 RU RU2018117360A patent/RU2018117360A/ru not_active Application Discontinuation
- 2016-12-02 MX MX2018005392A patent/MX391311B/es unknown
- 2016-12-02 HK HK18112080.6A patent/HK1252755B/en unknown
- 2016-12-02 WO PCT/US2016/064860 patent/WO2017096328A1/en not_active Ceased
- 2016-12-02 CA CA3004757A patent/CA3004757C/en active Active
- 2016-12-02 DK DK16822804.7T patent/DK3371310T3/da active
-
2017
- 2017-09-14 US US15/703,992 patent/US9970029B1/en active Active
-
2018
- 2018-05-03 IL IL259148A patent/IL259148B/en unknown
- 2018-05-04 US US15/971,863 patent/US10100333B2/en active Active
- 2018-05-07 ZA ZA2018/02968A patent/ZA201802968B/en unknown
- 2018-10-04 US US16/152,337 patent/US11505808B2/en active Active
-
2019
- 2019-10-07 AU AU2019240724A patent/AU2019240724B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3371310T3 (da) | Nucleinsyrekonstruerede targetnucleinsyrer | |
| IL271342A (en) | Nucleic acid-guided nucleases | |
| DK3523430T3 (da) | Manipulerede nukleinsyremålrettede nukleinsyrer | |
| IL254000B (en) | Nucleic acid sequence assembly | |
| IL264966B (en) | De novo synthesized nucleic acid libraries | |
| DK3341482T3 (da) | Kunstige nukleinsyremolekyler | |
| PL3118311T3 (pl) | Antysensowny kwas nukleinowy | |
| HUE047175T2 (hu) | Eljárások nukleinsavak tanulmányozására | |
| DK3448990T3 (da) | Forbedrede fremgangsmåder til modificering af målnukleinsyrer | |
| DK3234132T3 (da) | Ligand-modificerede dobbeltstrengede nukleinsyrer | |
| DK3981437T3 (da) | Nukleinsyrevacciner | |
| IL249574B (en) | Antisense nucleic acids | |
| SI3294325T1 (sl) | Krepitev učinka car-izdelanih t celic s cepljenjem z nukleinsko kislino | |
| DK3351633T3 (da) | Antisense-nukleinsyre | |
| DK3708668T3 (da) | Kunstigt nukleinsyremolekyle til forbedret proteinudtrykkelse | |
| DK3129487T3 (da) | Forbedrede nukleinsyrekonstruktioner til eukaryot genekspression | |
| GB201507119D0 (en) | Nucleic Acid Construct | |
| DK3620534T3 (da) | Crispr-cas sammensætninger af nucleinsyre-targeting nucleinsyrer | |
| GB201507115D0 (en) | Nucleic Acid Construct | |
| GB201507111D0 (en) | Nucleic acid construct | |
| GB201507104D0 (en) | Nucleic acid construct | |
| DK3094731T3 (da) | Saccharidmodificerede nukleinsyremolekyler | |
| DK3699289T3 (da) | Prøveklargøring til nukleinsyreamplifikation | |
| GB201507108D0 (en) | Nucleic acid construct | |
| LT3445743T (lt) | Aminorūgšties darinio provaistas |